João Anselmo1, Neal H Scherberg2, Alexandra M Dumitrescu2,3, Samuel Refetoff2,4,5. 1. 1 Department of Endocrinology and Nutrition, Hospital Divino Espírito Santo, Ponta Delgada, Azores, Portugal. 2. 2 Department of Medicine, The University of Chicago, Chicago, Illinois. 3. 3 Department of Molecular Medicine Metabolism and Nutrition, The University of Chicago, Chicago, Illinois. 4. 4 Department of Pediatrics, Committees on, The University of Chicago, Chicago, Illinois. 5. 5 Department of Genetics, The University of Chicago, Chicago, Illinois.
Abstract
Background: Evidence for transgenerational epigenetic inheritance in humans is still controversial, given the requirement to demonstrate persistence of the phenotype across three generations. A previous study showed that exposure of human and mouse embryos to high maternal thyroid hormone (TH) concentrations not only affects the newborns but also subsequently reduces thyrotroph sensitivity to TH during adult life. The current investigation set out to determine if this epigenetic effect is transmitted by humans not exposed in utero to high TH levels to their offspring. Methods: The study took advantage of the high frequency of intrauterine exposure to high TH in the Azorean wild-type population born to healthy mothers with high TH levels because of a heterozygous TH receptor beta gene mutation. Wild-type individuals from F2 (second) and F3 (third) generations were studied, whose parents and grandparents, respectively, were not exposed to high maternal TH levels. Twenty-six individuals belonging to 17 nuclear families were tested for their sensitivity to TH using their thyrotropin (TSH) response to thyrotropin-releasing hormone (TRH) after administration of liothyronine (LT3). Results: Preservation of reduced sensitivity to TH (RSTH) was found in descendants of males but not of females with likewise RSTH. In F2, offspring of fathers but not of mothers exposed to high TH levels had RSTH (TRH-stimulated TSH of 6.39 ± 0.63 vs 1.58 ± 0.41 mIU/L [p < 0.001], respectively, after treatment with LT3). In F3, whose parents nor themselves were exposed to TH excess during their fetal life, descendants of fathers and not mothers had RSTH (TRH-stimulated TSH of 4.60 ± 0.61 vs 1.37 ± 0.23 mIU/L [p < 0.01], respectively, after pretreatment with LT3). Conclusions: Since intrauterine total body and gonadal exposure to elevated TH can potentially affect only the F1 and F2, respectively, the results obtained from F3 confirm a true inheritance of an epigenetic effect, scarcely observed in humans. While the exact mechanism underlying the inheritance of this epigenetic effect remains unknown, it correlates with type 3 deiodinase overexpression demonstrated in pituitary glands of mice born to dams with high TH. This enzyme inactivates TH, and is encoded by an imprinted gene with specific parent of origin expression.
Background: Evidence for transgenerational epigenetic inheritance in humans is still controversial, given the requirement to demonstrate persistence of the phenotype across three generations. A previous study showed that exposure of human and mouse embryos to high maternal thyroid hormone (TH) concentrations not only affects the newborns but also subsequently reduces thyrotroph sensitivity to TH during adult life. The current investigation set out to determine if this epigenetic effect is transmitted by humans not exposed in utero to high TH levels to their offspring. Methods: The study took advantage of the high frequency of intrauterine exposure to high TH in the Azorean wild-type population born to healthy mothers with high TH levels because of a heterozygous TH receptor beta gene mutation. Wild-type individuals from F2 (second) and F3 (third) generations were studied, whose parents and grandparents, respectively, were not exposed to high maternal TH levels. Twenty-six individuals belonging to 17 nuclear families were tested for their sensitivity to TH using their thyrotropin (TSH) response to thyrotropin-releasing hormone (TRH) after administration of liothyronine (LT3). Results: Preservation of reduced sensitivity to TH (RSTH) was found in descendants of males but not of females with likewise RSTH. In F2, offspring of fathers but not of mothers exposed to high TH levels had RSTH (TRH-stimulated TSH of 6.39 ± 0.63 vs 1.58 ± 0.41 mIU/L [p < 0.001], respectively, after treatment with LT3). In F3, whose parents nor themselves were exposed to TH excess during their fetal life, descendants of fathers and not mothers had RSTH (TRH-stimulated TSH of 4.60 ± 0.61 vs 1.37 ± 0.23 mIU/L [p < 0.01], respectively, after pretreatment with LT3). Conclusions: Since intrauterine total body and gonadal exposure to elevated TH can potentially affect only the F1 and F2, respectively, the results obtained from F3 confirm a true inheritance of an epigenetic effect, scarcely observed in humans. While the exact mechanism underlying the inheritance of this epigenetic effect remains unknown, it correlates with type 3 deiodinase overexpression demonstrated in pituitary glands of mice born to dams with high TH. This enzyme inactivates TH, and is encoded by an imprinted gene with specific parent of origin expression.
Entities:
Keywords:
epigenetic; human; inheritance; reduced sensitivity to thyroid hormone; transgenerational
Authors: David S Cooper; Gerard M Doherty; Bryan R Haugen; Richard T Kloos; Stephanie L Lee; Susan J Mandel; Ernest L Mazzaferri; Bryan McIver; Steven I Sherman; R Michael Tuttle Journal: Thyroid Date: 2006-02 Impact factor: 6.568
Authors: Alfonso Massimiliano Ferrara; Kazumichi Onigata; Oya Ercan; Helen Woodhead; Roy E Weiss; Samuel Refetoff Journal: J Clin Endocrinol Metab Date: 2012-02-08 Impact factor: 5.958
Authors: Balázs Gereben; Ann Marie Zavacki; Scott Ribich; Brian W Kim; Stephen A Huang; Warner S Simonides; Anikó Zeöld; Antonio C Bianco Journal: Endocr Rev Date: 2008-09-24 Impact factor: 19.871
Authors: Megan P Hitchins; Robert W Rapkins; Chau-To Kwok; Sameer Srivastava; Justin J L Wong; Levon M Khachigian; Patsie Polly; Jack Goldblatt; Robyn L Ward Journal: Cancer Cell Date: 2011-08-16 Impact factor: 31.743
Authors: Arturo Hernandez; M Elena Martinez; Xiao-Hui Liao; Jacqueline Van Sande; Samuel Refetoff; Valerie Anne Galton; Donald L St Germain Journal: Endocrinology Date: 2007-09-06 Impact factor: 4.736
Authors: Hannah M A Robertson; Anil K P Narayanaswamy; Olivia Pereira; Shirley A Copland; Richard Herriot; Alistair W McKinlay; John S Bevan; Prakash Abraham Journal: Thyroid Date: 2014-12 Impact factor: 6.568
Authors: Ueli Grossniklaus; William G Kelly; Bill Kelly; Anne C Ferguson-Smith; Marcus Pembrey; Susan Lindquist Journal: Nat Rev Genet Date: 2013-03 Impact factor: 53.242
Authors: Paula Juiz-Valiña; María Cordido; Elena Outeiriño-Blanco; Sonia Pértega; Bárbara María Varela-Rodríguez; María Jesús García-Brao; Enrique Mena; Lara Pena-Bello; Susana Sangiao-Alvarellos; Fernando Cordido Journal: J Clin Med Date: 2020-01-28 Impact factor: 4.241
Authors: María Cordido; Paula Juiz-Valiña; Paula Urones; Susana Sangiao-Alvarellos; Fernando Cordido Journal: J Clin Med Date: 2022-02-28 Impact factor: 4.241